MRes in Medical Device Design and Entrepreneurship<\/a> which Professor James Moore launched in October 2013. <\/p>\n4. Impact, the buzz word of 2013 is also big in the US, although they generally refer to it as ‘broader impact’. As in the UK the funders, particularly the NSF, are now providing grants for outreach as part of research.<\/p>\n
5. Industry perception, although I think generally US awareness of bioengineering is higher than that of the UK there is still work to be done in industry. Particularly industry perception of the skillset of bioengineers vs. mechanical or electrical and electronic engineers. I am looking forward to working on this survey with some of my new US contacts that I have met with during this trip. <\/p>\n
Overall my views of the future growth of the discipline have only been encouraged through this trip. I have met many inspirational individuals on the trip so far who are leading the discipline academically and innovatively, and I feel very privileged to have had the honour to meet them all. <\/p>\n
Special thanks to:<\/strong>
\nProfessor Doug Lauffenburger, MIT
\nProfessor Roger Kamm, MIT
\nProfessor Ron Weiss, MIT
\nDaniel Darling, MIT
\nProfessor Scott Manalis, MIT
\nDr Agi Stachowiak, MIT
\nDr Natalie Kuldell, MIT
\nProfessor Michael Cima, MIT<\/p>\nProfessor Solomon Eisenberg, Boston University<\/p>\n
Professor Sandra Shefelbine, Northeastern University
\nClaire Duggan, Northeastern University
\nKaren Kelley, Northeastern University<\/p>\n
Professor Clark Hung, Columbia University<\/p>\n
Doug Beizer, Biomedical Engineering Society<\/p>\n
Dr Karen Borgsmiller, Johns Hopkins University
\nChristine Newman, Johns Hopkins University
\nAlisha Sparks, Johns Hopkins University
\nProfessor Youseph Yazdi, Johns Hopkins University<\/p>\n
…not a bad first week \ud83d\ude42<\/p>\n","protected":false},"excerpt":{"rendered":"
I have now finished my first week of the US bioengineering trip. This post is a synopsis of what I have learnt so far. 1. The UK and the USA landscape of bioengineering isn’t as different as I had expected. 2. There is heterogeneity in the bioengineering departments, with different Departments focusing on different aspects […]<\/p>\n","protected":false},"author":677,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/posts\/59","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/users\/677"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/comments?post=59"}],"version-history":[{"count":3,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/posts\/59\/revisions"}],"predecessor-version":[{"id":87,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/posts\/59\/revisions\/87"}],"wp:attachment":[{"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/media?parent=59"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/categories?post=59"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs-staging.imperial.ac.uk\/bioengineering\/wp-json\/wp\/v2\/tags?post=59"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}